{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:33:45Z","timestamp":1795095225944,"version":"4.10.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2017-I2M-2-001"],"award-info":[{"award-number":["2017-I2M-2-001"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC0901502"],"award-info":[{"award-number":["2016YFC0901502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570061"],"award-info":[{"award-number":["81570061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sporadic lymphangioleiomyomatosis (S-LAM) is a rare neoplasm with heterogeneous clinical features that is conventionally considered to be related to <jats:italic>TSC2<\/jats:italic>. This study serves to elucidate the mutation landscape and potential correlation between S-LAM genomic profiles and clinical phenotypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Genomic profiles of 22 S-LAM patients were obtained by sequencing genomic DNA and cell-free DNA from various specimens using an NGS (next-generation sequencing)-based tumor-driver gene panel. Detected mutations were summarized. Symptoms, serum vascular endothelial growth factor D (VEGF-D) values, pulmonary function, and six-minute walk distance (6MWD) were compared among groups with different <jats:italic>TSC2<\/jats:italic> status and genotypes to analyze genotype\u2013phenotype correlations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>67 Variants in 43 genes were detected, with a <jats:italic>TSC2<\/jats:italic> mutation detection rate of 68.2%. The <jats:italic>TSC2<\/jats:italic> detection rate was similar in specimens obtained either through transbronchial lung biopsy (TBLB) or surgical lung biopsy (70.0% vs. 69.2%, <jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). A novel mutation in <jats:italic>VEZF1<\/jats:italic> (c.A659G) was detected in four participants and may represent a mild disease state. <jats:italic>TSC2<\/jats:italic> mutation was significantly related to a shorter 6MWD (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), and a higher percentage of VEGF-D over 800\u00a0pg\/mL (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05); stop-gain mutation was significantly related to a higher prevalence of pneumothorax.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Tumor-driver mutations in genes other than <jats:italic>TSC2<\/jats:italic> may have a role in S-LAM, and TBLB specimens are practical alternatives for genomic analysis. <jats:italic>TSC2<\/jats:italic> mutation detectability and types are related to the disease severity and phenotypes of S-LAM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-022-02154-0","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T05:02:25Z","timestamp":1663477345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Gene mutations in sporadic lymphangioleiomyomatosis and genotype\u2013phenotype correlation analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Jiannan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshuai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongsheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7662-531X","authenticated-orcid":false,"given":"Kai-Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,18]]},"reference":[{"issue":"18","key":"2154_CR1","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1056\/NEJM199011013231807","volume":"323","author":"JR Taylor","year":"1990","unstructured":"Taylor JR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med. 1990;323(18):1254\u201360.","journal-title":"N Engl J Med"},{"issue":"2","key":"2154_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1378\/chest.07-0898","volume":"133","author":"FX McCormack","year":"2008","unstructured":"McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest. 2008;133(2):507\u201316.","journal-title":"Chest"},{"issue":"11","key":"2154_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/qjmed\/hcr116","volume":"104","author":"EC Harknett","year":"2011","unstructured":"Harknett EC, Chang WY, Byrnes S, Johnson J, Lazor R, Cohen MM, et al. Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM. 2011;104(11):971\u20139.","journal-title":"QJM"},{"issue":"4","key":"2154_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1517\/21678707.2016.1148597","volume":"4","author":"AM Taveira-DaSilva","year":"2016","unstructured":"Taveira-DaSilva AM, Moss J. Epidemiology, pathogenesis and diagnosis of lymphangioleiomyomatosis. Expert Opin Orphan Drugs. 2016;4(4):369\u201378.","journal-title":"Expert Opin Orphan Drugs"},{"issue":"1","key":"2154_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1183\/09031936.00076209","volume":"35","author":"SR Johnson","year":"2010","unstructured":"Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J. 2010;35(1):14\u201326.","journal-title":"Eur Respir J"},{"issue":"10","key":"2154_CR6","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1164\/rccm.201709-1965ST","volume":"196","author":"N Gupta","year":"2017","unstructured":"Gupta N, Finlay GA, Kotloff RM, Strange C, Wilson KC, Young LR, et al. Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An Official American Thoracic Society\/Japanese Respiratory Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2017;196(10):1337\u201348.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2154_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","volume":"173","author":"JH Ryu","year":"2006","unstructured":"Ryu JH, Moss J, Beck GJ, Lee JC, Brown KK, Chapman JT, et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med. 2006;173(1):105\u201311.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2154_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1086\/301804","volume":"62","author":"TA Smolarek","year":"1998","unstructured":"Smolarek TA, Wessner LL, McCormack FX, Mylet JC, Menon AG, Henske EP. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet. 1998;62(4):810\u20135.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"2154_CR9","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","volume":"97","author":"T Carsillo","year":"2000","unstructured":"Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA. 2000;97(11):6085\u201390.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2154_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1164\/ajrccm.187.6.663","volume":"187","author":"KR Badri","year":"2013","unstructured":"Badri KR, Gao L, Hyjek E, Schuger N, Schuger L, Qin W, et al. Exonic mutations of TSC2\/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2013;187(6):663\u20135.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2154_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00439-015-1611-0","volume":"135","author":"A Fujita","year":"2016","unstructured":"Fujita A, Ando K, Kobayashi E, Mitani K, Okudera K, Nakashima M, et al. Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing. Hum Genet. 2016;135(1):61\u20138.","journal-title":"Hum Genet"},{"issue":"9","key":"2154_CR12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/modpathol.2017.52","volume":"30","author":"SJ Murphy","year":"2017","unstructured":"Murphy SJ, Terra SB, Harris FR, Nasir A, Voss JS, Smadbeck JB, et al. Genomic rearrangements in sporadic lymphangioleiomyomatosis: an evolving genetic story. Mod Pathol. 2017;30(9):1223\u201333.","journal-title":"Mod Pathol"},{"issue":"11","key":"2154_CR13","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1164\/rccm.201003-0489OC","volume":"182","author":"X Cai","year":"2010","unstructured":"Cai X, Pacheco-Rodriguez G, Fan QY, Haughey M, Samsel L, El-Chemaly S, et al. Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2010;182(11):1410\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2154_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ijc.32511","volume":"146","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wang MJ, Wang W, Zhao JY, Wu JL, Liu YP, et al. Identification of driver genes and somatic mutations in cell-free DNA of patients with pulmonary lymphangioleiomyomatosis. Int J Cancer. 2020;146(1):103\u201314.","journal-title":"Int J Cancer"},{"issue":"12","key":"2154_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226400","volume":"14","author":"J Liu","year":"2019","unstructured":"Liu J, Zhao W, Ou X, Zhao Z, Hu C, Sun M, et al. Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM). PLoS ONE. 2019;14(12): e0226400.","journal-title":"PLoS ONE"},{"issue":"1","key":"2154_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10038-002-8651-8","volume":"47","author":"T Sato","year":"2002","unstructured":"Sato T, Seyama K, Fujii H, Maruyama H, Setoguchi Y, Iwakami S, et al. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet. 2002;47(1):20\u20138.","journal-title":"J Hum Genet"},{"issue":"2","key":"2154_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2796.2004.01356.x","volume":"256","author":"T Sato","year":"2004","unstructured":"Sato T, Seyama K, Kumasaka T, Fujii H, Setoguchi Y, Shirai T, et al. A patient with TSC1 germline mutation whose clinical phenotype was limited to lymphangioleiomyomatosis. J Intern Med. 2004;256(2):166\u201373.","journal-title":"J Intern Med"},{"issue":"5","key":"2154_CR18","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1158\/0008-5472.CAN-06-1122","volume":"67","author":"J D'Armiento","year":"2007","unstructured":"D\u2019Armiento J, Imai K, Schiltz J, Kolesnekova N, Sternberg D, Benson K, et al. Identification of the benign mesenchymal tumor gene HMGA2 in lymphangiomyomatosis. Cancer Res. 2007;67(5):1902\u20139.","journal-title":"Cancer Res"},{"issue":"6","key":"2154_CR19","doi-asserted-by":"publisher","first-page":"1900329","DOI":"10.1183\/13993003.00329-2019","volume":"53","author":"W Kim","year":"2019","unstructured":"Kim W, Giannikou K, Dreier JR, Lee S, Tyburczy ME, Silverman EK, et al. A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis. Eur Respir J. 2019;53(6):1900329.","journal-title":"Eur Respir J"},{"issue":"3","key":"2154_CR20","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.4049\/jimmunol.182.3.1270","volume":"182","author":"G Pacheco-Rodriguez","year":"2009","unstructured":"Pacheco-Rodriguez G, Kumaki F, Steagall WK, Zhang Y, Ikeda Y, Lin JP, et al. Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene. J Immunol. 2009;182(3):1270\u20137.","journal-title":"J Immunol"},{"issue":"92","key":"2154_CR21","doi-asserted-by":"publisher","first-page":"92ra66","DOI":"10.1126\/scitranslmed.3002543","volume":"3","author":"J Wu","year":"2011","unstructured":"Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, Eshleman JR, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3(92):92ra66.","journal-title":"Sci Transl Med."},{"issue":"1","key":"2154_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"Society AT","year":"2002","unstructured":"Society AT. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"2154_CR23","unstructured":"Downloading IBM SPSS Statistics 25. https:\/\/www.ibm.com\/support\/pages\/downloading-ibm-spss-statistics-25. Accessed 16 April 2021."},{"key":"2154_CR24","unstructured":"The cBioPortal mutation mapper. https:\/\/www.cbioportal.org\/mutation_mapper. Accessed 12 April 2021."},{"issue":"10","key":"2154_CR25","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1164\/rccm.201912-2445OC","volume":"202","author":"M Guo","year":"2020","unstructured":"Guo M, Yu JJ, Perl AK, Wikenheiser-Brokamp KA, Riccetti M, Zhang EY, et al. Single-cell transcriptomic analysis identifies a unique pulmonary lymphangioleiomyomatosis cell. Am J Respir Crit Care Med. 2020;202(10):1373\u201387.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2154_CR26","doi-asserted-by":"publisher","first-page":"1900938","DOI":"10.1183\/13993003.00938-2019","volume":"54","author":"B Og\u00f3rek","year":"2019","unstructured":"Og\u00f3rek B, Hamieh L, Lasseter K, Bagwe S, Machado T, Herranz-Ors C, et al. Generalised mosaicism for TSC2 mutation in isolated lymphangioleiomyomatosis. Eur Respir J. 2019;54(4):1900938.","journal-title":"Eur Respir J"},{"issue":"28","key":"2154_CR27","doi-asserted-by":"publisher","first-page":"11109","DOI":"10.1074\/jbc.RA118.002911","volume":"293","author":"L AlAbdi","year":"2018","unstructured":"AlAbdi L, He M, Yang Q, Norvil AB, Gowher H. The transcription factor Vezf1 represses the expression of the antiangiogenic factor Cited2 in endothelial cells. J Biol Chem. 2018;293(28):11109\u201318.","journal-title":"J Biol Chem"},{"issue":"4","key":"2154_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1440-1843.2007.01101.x","volume":"12","author":"M Hayashida","year":"2007","unstructured":"Hayashida M, Seyama K, Inoue Y, Fujimoto K, Kubo K. The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors. Respirology. 2007;12(4):523\u201330.","journal-title":"Respirology"},{"issue":"11","key":"2154_CR29","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1164\/rccm.201807-1212CI","volume":"199","author":"PM Boone","year":"2019","unstructured":"Boone PM, Scott RM, Marciniak SJ, Henske EP, Raby BA. The genetics of pneumothorax. Am J Respir Crit Care Med. 2019;199(11):1344\u201357.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02154-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-02154-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02154-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T05:02:40Z","timestamp":1663477360000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-02154-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,18]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2154"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-02154-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,18]]},"assertion":[{"value":"14 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Peking Union Medical College Hospital Ethics Committee (JS-964). Written informed consent was obtained from all participants. All experiments were performed in accordance with relevant guidelines and regulations. The study passed the bioethics evaluation by the Human Genetic Resources Management Committee under the Ministry of Science and Technology of People's Republic of China and was approved for data publication (Record File ID 2022BAT1769).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"354"}}